Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Osteosarcoma.
Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, Livingston JA, Roberts RD, Strauss SJ, Gorlick R. Beird HC, et al. Among authors: gill j. Nat Rev Dis Primers. 2022 Dec 8;8(1):77. doi: 10.1038/s41572-022-00409-y. Nat Rev Dis Primers. 2022. PMID: 36481668 Free article. Review.
Current and future therapeutic approaches for osteosarcoma.
Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Harrison DJ, et al. Among authors: gill jd. Expert Rev Anticancer Ther. 2018 Jan;18(1):39-50. doi: 10.1080/14737140.2018.1413939. Epub 2017 Dec 14. Expert Rev Anticancer Ther. 2018. PMID: 29210294 Review.
HER2-Targeted Therapy in Osteosarcoma.
Gill J, Hingorani P, Roth M, Gorlick R. Gill J, et al. Adv Exp Med Biol. 2020;1257:55-66. doi: 10.1007/978-3-030-43032-0_5. Adv Exp Med Biol. 2020. PMID: 32483730 Review.
Advancing therapy for osteosarcoma.
Gill J, Gorlick R. Gill J, et al. Nat Rev Clin Oncol. 2021 Oct;18(10):609-624. doi: 10.1038/s41571-021-00519-8. Epub 2021 Jun 15. Nat Rev Clin Oncol. 2021. PMID: 34131316 Review.
Author Correction: Osteosarcoma.
Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, Livingston JA, Roberts RD, Strauss SJ, Gorlick R. Beird HC, et al. Among authors: gill j. Nat Rev Dis Primers. 2022 Dec 30;8(1):82. doi: 10.1038/s41572-022-00416-z. Nat Rev Dis Primers. 2022. PMID: 36585406 No abstract available.
New targets and approaches in osteosarcoma.
Gill J, Ahluwalia MK, Geller D, Gorlick R. Gill J, et al. Pharmacol Ther. 2013 Jan;137(1):89-99. doi: 10.1016/j.pharmthera.2012.09.003. Epub 2012 Sep 14. Pharmacol Ther. 2013. PMID: 22983152 Review.
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.
Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. Gorlick S, et al. Among authors: gill j. Pediatr Blood Cancer. 2014 Sep;61(9):1558-64. doi: 10.1002/pbc.25074. Epub 2014 Apr 22. Pediatr Blood Cancer. 2014. PMID: 24753182 Free PMC article.
HER-2 involvement in osteosarcoma.
Gill J, Geller D, Gorlick R. Gill J, et al. Adv Exp Med Biol. 2014;804:161-77. doi: 10.1007/978-3-319-04843-7_9. Adv Exp Med Biol. 2014. PMID: 24924174 Review.
3,244 results